Morphological and immunophenotypic features of human CD34+ hematopoietic stem cell-engrafted NSG mice by Blümich, Sandra Larissa Elena








Morphological and immunophenotypic features of human CD34+
hematopoietic stem cell-engrafted NSG mice
Blümich, Sandra Larissa Elena





Blümich, Sandra Larissa Elena. Morphological and immunophenotypic features of human CD34+ hematopoi-




Institut für Veterinärpathologie 
der Vetsuisse-Fakultät Universität Zürich 
 
Direktorin Institut: Prof. Dr. med. vet Anja Kipar 
 
Arbeit unter wissenschaftlicher Betreuung von 
Prof. Dr. med. vet Anja Kipar 
 
Morphological and immunophenotypic features of human CD34+ 




zur Erlangung der Doktorwürde der 





Sandra Larissa Elena Blümich 
 
Tierärztin 
aus Berlin, Deutschland 
 
genehmigt auf Antrag von 
 
Prof. Dr. med. vet Anja Kipar, Referentin 













1 Abstract ……………………………………………………………………………………4 
2 Zusammenfassung ………………………………………………………………….……5 
3 Submitted manuscript …………………………………………………………..…..6 - 38 
 Introduction ……………………………………………………………………….….6 
 Materials and Methods …………………………………………………...…………7 
 Results ……………………………………………………………………………....12 
 Discussion …………………………………………………………………………..30 
 References ………………………………………………………………………….35 
4 Danksagung 





Vetsuisse Faculty University of Zurich (2020) 
Sandra Larissa Elena Blümich 
Institute of Veterinary Pathology 
ivpz@vetpath.uzh.ch 
Morphological and immunophenotypic features of human CD34+ 
hematopoietic stem cell-engrafted NSG mice 
Immunodeficient mice engrafted with human immune system cells are animal models 
for the study of human diseases. Immunophenotyping of these mice mostly focuses 
on engraftment rates and cellular differentiation in blood and secondary lymphoid 
organs and is performed by FACS analysis; there is limited information on the 
morphological aspects of the engraftment and the prevalence of histopathological 
lesions. 
We histologically examined young NSG mice, naïve and engrafted with CD34+ 
human hemopoietic stem cells (HSC), undertook quantitative immunohistochemical 
analyses and compared the results with those of FACS analyses. 
Besides well-known incidental organ findings, NSG mice only exhibited a case of 
lymphoblastic lymphoma in a 6-month-old animal, whereas in mice engrafted with 
human HSC nephropathy, ovarian atrophy, cataract and abnormal retinal 
development secondary to irradiation were frequent. The latter also often exhibited 
multisystemic granulomatous inflammatory infiltrates, interpreted as graft versus host 
disease. They had variable repopulation rates in hemolymphatic organs, which did 
not always parallel the engraftment levels measured via FACS.  
The study provides a catalogue of the most common pathological features to 
consider in young NSG mice without and after human HSC engraftment. This and the 
knowledge on the relevant features of engraftment at tissue level will assist in the 
morphological assessment of this animal model in experimental settings. 
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Morphologische und immunphänotypische Eigenschaften von CD34+ 
stammzelltransplantierten NSG Mäusen 
Mit humanen Immunzellen transplantierte immundefiziente Mäuse dienen als Modelle 
zur Untersuchung menschlicher Krankheiten. Ihre Immunphänotypisierung erfolgt 
durch Quantifizierung der Transplantationsrate und der zellulären Differenzierung in 
Blut und lymphatischen Organen mittels FACS-Analyse. Bisher liegen kaum 
Informationen zu pathologischen Folgen und morphologischen Aspekten der 
Transplantation vor. 
Junge, naive oder mit CD34+ humanen Stammzellen transplantierte NSG-Mäuse 
wurden histologisch und quantitativ immunhistologisch untersucht. Letztere dienten 
zum Vergleich mit parallel durchgeführten FACS-Analysen. 
Neben bekannten Zufallsbefunden an Organen fand sich bei den naiven NSG-
Mäusen lediglich ein Fall eines lymphoblastischen Lymphoms bei einem 6 Monate 
alten Tier, bei transplantierten Mäusen dagegen häufig eine strahlenbedingte 
Nephropathie, Ovaratrophie, Katarakt und abnormale Entwicklung der Retina. 
Letztere Tiere wiesen oft multisystemische granulomatöse Entzündungsherde auf, 
die als Graft versus Host Disease interpretiert wurden. Die Repopulationsraten im 
hämolymphatischen Gewebe waren variabel und korrelierten nicht immer mit den 
FACS-Ergebnissen. 
Die Studie liefert einen Katalog der häufigsten pathologischen Veränderungen bei 
jungen NSG-Mäusen ohne und nach humaner Stammzelltransplantation. Dieser 
kann, ebenso wie das neu gewonnene Wissen zum Effekt der Transplantation im 
Gewebe, für morphologische Untersuchungen unter experimentellen Bedingungen 
hilfreich sein. 
 
Stichwörter: NSG Mäuse, CD34+ Stammzellentransplantation, humanisierte Mäuse, 






Morphological and immunophenotypic features of human CD34+ hematopoietic 
stem cell-engrafted NSG mice 
Introduction 
Recent advances in the generation of humanized murine models, featuring 
immunodeficient mice engrafted with human immune system cells, have brought 
tangible breakthroughs in numerous research fields, such as the preclinical 
development of immunotherapeutic agents and the study of infectious, metabolic and 
autoimmune diseases. Progress has been facilitated by the optimisation of 
immunodeficient mouse models, which, being deprived of acquired and innate 
immunity, can be transplanted with human cells that eventually develop into a 
variably functional immune system in the model.9,40,49,53  
Among the numerous immunodeficient mouse strains available, the NOD-scid IL-
2Rɣnull (NSG) mouse represents the currently most widely used option for successful 
humanisation of the immune system, showing one of the highest engraftment rates 
among the various strains.27,55 NSG mice are non-obese diabetic (NOD) mice 
bearing the Prkdcscid mutation and a genetic deletion of the common γ chain of the IL-
2 receptor. Accordingly, they exhibit defects in the lymphoid cell development, lacking 
both innate and adaptive lymphocytes, and have diminished complement activity due 
to C5 deficiency.9,23,44 In contrast to their NOD/scid predecessors, NSG mice are not 
prone to develop thymic lymphomas; they have a long life span of about two 
years.9,22 Functional immune system abnormalities in immunodeficient mice are 
associated with abnormal development of the primary and secondary lymphoid 
organs; however, the morphological equivalents of the latter vary across the available 
models.42 NSG mice, for example, exhibit a small spleen, thymus and lymph nodes 
that lack lymphoid structures and are composed almost exclusively of reticular 
stromal cells.41,43,44 
Immunodeficient mice can be transiently or stably humanized by administration of 
human mature lymphoid or CD34+ hematopoietic stem cells (HSC), respectively.53 
Most models allow multi-lineage human immune cell engraftment and both the 
acquired and innate human immune system components develop at variable 
quantities. The present study focuses on CD34+ HSC humanized NSG (hu-NSG) 
mice, a model in which T and B cell engraftment is generally successful, though 
without consistent immunoglobulin (Ig) class switching and only IgM production by B 
cells.18,40,48 Hu-NSG mice exhibit human dendritic cells, NK cells and myeloid cells 
including neutrophils.24,31,52 However, the latter two are generally seen at low 
numbers, and seem to be defective in their maturation and function.18,22,40,49 It has 
been shown that the reconstituted human leukocytes form variably sized aggregates 
in the lymphoid organs of these mice, which in general do not form distinctive 
secondary lymphoid structures such as lymphoid follicles in spleen and lymph 
nodes.22,49,52 In the thymus, repopulation appears to be more efficient in 
immunodeficient mice transplanted shortly after birth, whilst in mice engrafted at adult 
age the thymus is less prone to support human cell engraftment.7,54 In the bone 
marrow the proportion of lymphoid and myeloid cells varies, as different published 
studies indicate.52,54  
Effective engraftment in hu-NSG mice is generally determined by fluorescent 
activated cell sorting (FACS) analysis of the blood, usually at 12-16 weeks post-
engraftment. The FACS data suggest that depending on the age of the mice, the 




engraftment can vary substantially.22,25 So far, most of the immunophenotyping data 
that is available for these mice are also based on FACS analyses, carried out on 
circulating and organ-specific immune cells at different endpoints.7,25,35,48 
Accordingly, there is very limited information concerning the in situ aspects of 
engraftment, in particular in the hemolymphatic tissues and, specifically, how these 
correlate with the engraftment rates and cellular differentiation determined by FACS. 
Furthermore, little is known about the incidence of spontaneous diseases and 
common histopathological lesions in hu-NSG mice, and even in NSG mice. 
Information about the spectrum of histopathological lesions occurring spontaneously 
in NSG mice is mainly limited to the prevalence of neoplastic findings in the NOD 
background strain21 or a few reports on the most common causes of mortality and 
morbidity and age-related lesions in old NSG mice housed in conventional mouse 
facilities.16,41 In the few reports available about hu-NSG mice, spontaneous changes 
were generally mentioned alongside the findings relevant to the study instead of 
being a focus of investigation.8,30,41,54 However, a recent study reported 
histopathological lesions that provide evidence of the occurrence of graft versus host 
disease (GvHD) in HSC hu-NSG mice.11 Considering the increasing use of 
humanized mice in efficacy and safety studies, including regulatory safety 
assessment, this knowledge gap needs to be addressed and better characterization 
of the model is warranted to consolidate its translatability.  
The present study aimed to characterize the morphological phenotype of NSG mice 
and their humanized counterpart, the CD34+ hu-NSG murine model generated via 
perinatal intrahepatic injection of human CD34+ fetal liver cells into NSG mice after 
preconditioning irradiation. In addition, the histological features of the hemolymphatic 
organs were assessed, with particular emphasis on the presence and distribution of 
murine and human leukocytes, and the occurrence and prevalence of GvHD. We 
found high variability in the levels of human cell engraftment in the blood of hu-NSG 
mice within the same experiment and hypothesized that this is reflected by a similarly 
variable reconstitution in the lymphoid organs. In order to evaluate whether effective 
and non-effective engraftment would be reflected in the tissues we undertook a 
quantitative, morphometric immunophenotypic analysis on a representative group of 
mice that allowed an assessment of engraftment rates at in situ level and served to 
compare organ repopulation with blood reconstitution. Our results also provide 
evidence of GvHD as a relevant cause of morbidity and subclinical disease in this hu-
NSG mouse model. 
 
Materials and Methods 
 
Animals 
The study was undertaken on NOD-scid IL-2Rɣnull (NSG) mice from a breeding 
colony established in a research facility at the Institute of Experimental Immunology, 
University of Zurich, Switzerland from animals originally purchased from Jackson 
Laboratories (Bar Harbor, USA). Animals were housed in groups of up to five males 
or females respectively and fed ad libitum with conventional diet (M/R Haltung 
Extrudat, Alleinfuttermittel für Mäuse und Ratten, 3436; Granovit AG, Kaiseraugst, 
Switzerland). Water was provided ad libitum, the day and night cycle included 12 
hours of light, from 6 am to 6 pm. The colony was maintained under specific 




bacterial, and parasitic pathogens listed in the FELASA recommendations,33 except 
for mouse norovirus (MNV) and Helicobacter.  
The study cohort comprised a total of 109 mice. Among these were 48 NSG mice (31 
males, 17 females) that did not receive any treatment. Of these, 10 (6 males, 4 
females) were culled at 1-3 months of age, representing animals bred for, but not 
used in humanization experiments. Thirty-eight (25 males, 13 females) were breeding 
animals that were culled at 6 months of age, at the end of their breeding career. The 
second cohort of 61 hu-NSG mice (31 males, 30 females) were subjected to human 
cell engraftment and culled at the age of 3-5 months (deficiently humanized mice (n = 
22; <15% hCD45+ cells in peripheral blood after reconstitution): 3 months, efficiently 
humanized mice (n = 39): 4-5 months), at termination of an experiment to investigate 
the effects of Epstein-Barr virus infection on the immune system, in which they 
served as the non-infected control group. As part of the above-mentioned experiment 
on Epstein-Barr virus infection, the animals were injected intraperitoneally with 100 µl 
PBS at 12 to 14 weeks after irradiation. At the age of 4 months, 4 of these animals, 2 
males and 2 females, developed progressive weight loss and signs of unease such 
as hunched posture, rough coat and reddened skin, and had to be euthanized. 
After reconstitution, mice were clinically checked daily for three days, and then three 
times a week until weaning. A weekly check was performed on mice four weeks and 
older, including naïve NSG mice. 
 
Human Tissue Engraftment 
CD34+ HSC were isolated from fetal livers (Advanced Bioscience Resources, CA, 
USA) following established protocols.46 Cells were frozen in liquid nitrogen prior to 
their use in the engraftment experiments. At the age of 1-6 days, NSG mice (n=61) 
were each irradiated with 1Gy (preconditioning), using a “Rad Source 2000” 
equipped with an X-ray source and injected intrahepatically 5-7 hours later with 1-
3x105 CD34+ human HSC. After 10-12 weeks, blood was collected via the tail vein 
and analyzed by FACS. 
 
Ethics Statement 
All animal protocols were in accordance with the Swiss Animal Welfare Act, 
Tierschutzgesetz (TSchG) and were approved by the veterinary office of the canton 
of Zurich, Switzerland (protocols 148/2011, 209/2014 and 159/17). The studies 
involving human samples were reviewed and approved by the cantonal ethics 
committee of Zurich, Switzerland (protocol KEK-StV-Nr.19/08, KEK-ZH-Nr. 2010-
0057 and 2019-00837). 
  
Macroscopic and Histological Examination 
Mice were euthanized by 100% carbon dioxide asphyxiation, followed by 
exsanguination and creation of a pneumothorax. A full necropsy was conducted 
immediately after death on each mouse and a standard selection of organs, 
hemolymphatic tissues, as well as bones and joints were sampled and fixed in 10% 
neutral buffered formalin for 48-120 hours, then trimmed and routinely paraffin wax-
embedded following a predefined blocking pattern. Consecutive sections (3-5 µm) 
were prepared and routinely stained with hematoxylin and eosin (HE), special stains 
(when appropriate) or subjected to immunohistochemical staining. Examined tissues 
were adrenal glands, brain, eyes, female genital tract (mammary gland, ovaries, 
uterus, vagina), gastrointestinal tract (stomach, duodenum, jejunum, ileum, cecum, 
colon and rectum), Harderian gland, heart, kidneys, liver with gall bladder, lungs, 




glands, skeletal muscle (Musculus quadriceps femoris), skin, spinal cord, tongue, and 
urinary bladder. Examined hemolymphatic tissues were bone marrow from several 
locations (see bones), lymph nodes [cervical (one lymph node of the cervical chain: 
mandibular, accessory mandibular or superficial parotid), mesenteric (colic or 
jejunal), proper axillary] (in most animals, not all three lymph nodes were successfully 
sampled as these could not be identified grossly), spleen (1-2 cross sections), and 
thymus. Since thymus and lymph nodes were difficult to grossly identify especially in 
NSG mice, tissue in the corresponding area was collected and included in the 
paraffin block. Bones (sternum, femur and tibia with femorotibial joint, spinal column) 
as well as the head with nasal and oral cavities and teeth were also collected. After 
fixation, these were decalcified for 3-5 days in a mild decalcifying solution (RDF, Mild 
Decalcifier, CellPath, Newtown, UK), followed by paraffin embedding. Special stains 
were applied when considered necessary and comprised the Gram, Giemsa, Grocott, 
and Ziehl-Neelsen stains as well as the Periodic acid Schiff reaction). 
 
Immunohistochemistry 
Immunohistochemistry was applied to detect cells of human origin (Ku80+), human 
and mouse leukocytes (hCD45+, mCD45+), T cells (CD3+, CD4+, CD8+), human and 
mouse B cells (CD45R-B220+ and CD20+, respectively, monocytes/macrophages 
(calprotectin+, Iba1+, F4/80+, lysozyme+) and MHC II expression. Antibodies and 





Table 1. Immunohistochemistry and FACS analysis 
A. Antibodies and detection methods used for immunohistochemistry 
 
Antigen Cells detected 
(human, murine) 
 Antibody (clone) Antigen 
retrieval 
Detection method 
hCD45 Human leukocytes pAB rabbit anti-human 
CD45a 
CB pH 6.0, 
96°C, 30 min 
1:500, 60 min, RT, 
HRP Envision Rbe 
mCD45 Murine leukocytes mAB rat anti-mouse 
CD45 (I3/2.3) a 
CB pH 6.0, 
96°C, 30 min 
1:100, ON, RT, 
HRP Envision Rbe 
Ku80 Human cells mAB rabbit anti-human 
Ku80 (C48E7)b 
TE pH 9.0, 
96°C, 30 min 
1:200, ON, 4 °C, 
HRP Envision. Rbe 
Iba1 Human and murine 
macrophages  
pAB rabbit anti-human 
Iba1c 
CB pH 6.0, 
96°C, 30 min 
1:750, 60 min, RT, 
HRP Envision Rbe 
F4/80 Mature murine 
macrophages 
mAB rabbit anti-mouse 
F4/80 (SP115)d 
TE pH 9.0, 
96°C, 30 min 
1:150, 2 h, 37 °C, 
Omni Ultra Map Kit 
Rb (Discovery) 
Lysozyme Human and murine 
macrophages, 
neutrophils 
pAB rabbit anti-human 
lysozymee 
Proteinase Ke, 
RT, 5 min 
1:400, 60min, RT, 
HRP Envision Rbe 
CD45R  Murine B cells, 
reported to cross 
react with human  
mAB rat anti-mouse 
CD45R/B220 (RA3-
6B2)f 
CB pH 6.0, 
96°C, 30 min 
1:800, 60  min, RT, 
HRP Envision Rbe 
CD3 Human and murine 
T cells 









TE pH 9.0, 
96°C, 30 min 
CB pH 6.0, 
96°C, 30 min 
1:900, 1 h, 37 °C, 
Omni Ultra Map Kit 
Rb (Discovery) 
1:100, 30 min, RT, 
Omni Ultra Map Kit 
Rb (Discovery)  
Calprotectin 
CD4 Human and murine 
T helper cells 
mAB rabbit anti-mouse 
CD4 (EPR19514)a 
CB pH 6.0 
RT, 2 h 
1:250, 1 h, RT, 
HRP Envision Rbe 
CD8 Human and murine 
cytotoxic T cells 
mAB rabbit anti-mouse 
CD8 (D4W2Z)b 
CB pH 6.0 
100°C, 20 min 
1:50, 10 min, RT, 
Refine Detection 
Kit Mixed DABh 
CD20 Human and murine 
B cells 
pAB rabbita CB pH 6.0 
100°C, 20 min 
1:400, 37°C, 1 h, 
Omni Ultra Map Kit 
Rb (Discovery) 
Legend: mAB – monoclonal antibody; pAB – polyclonal antibody; CB – citrate buffer; TE – Tris-EDTA buffer; ON – 
overnight; RT – room temperature; Rb - rabbit 
Commercial providers: 
aAbcam, Cambridge, UK 
bCell Signaling Technology, Leiden, The Netherlands 
cWAKO, Osaka, Japan 
dInvitrogen/Thermo Fisher Scientific, Waltham, MA, USA 
eDako, Glastrup, Denmark 
fBD Pharmigen, Franklin Lakes, USA 
gSpring Bioscience, Ventana Medical Systems, Tucson, USA 





B. Antibodies applied in the FACS analysis to detect human cells. 
Antigen Cells detected Antibody and fluorophore (clone) Dilution 
CD45 Leukocytes mAB hCD45 Pacific Blue (HI30)a 1:500 
CD3* T cells mAB CD3 PE (UCHT1)a 
mAB CD3 BV785(OKT3)a 
1:100 
1:100 
CD4* T helper cells mAB CD4 APC-Cy7 (RPA-T4)a 
mAB CD4 BV605 (OKT4)a 
1:100 
1:100 
CD8* Cytotoxic T cells mAB CD8 PerCP (SK1)a 1:100 
HLA-DR* Activated leukocytes mAB HLA-DR FITC (L243)a 
mAB HLA-DR PE-Dazzle 594 (L243)a 
1:200 
1:200 
CD19* B cells mAB CD19 Pe-Cy7 (HIB19)a 
mAB CD19 A700 (HIB19)a 
1:100 
1:50 
NKp46* NK cells mAB NKp46 APC (9E2)b 1:100 
 
Legend: mAB – mouse monoclonal antibody 
*Analysis was conducted after gating for hCD45 in order to only include human cells for subsequent FACS 
analysis. 
Commercial Providers: 
aBiolegend, San Diego, USA 
bBD Pharmigen Franklin Lakes, USA 
 
 
Histological Scoring and Histomorphometry 
All tissues/organs were examined for histopathological changes which were 
diagnosed following the International Harmonization of Nomenclature and Diagnostic 
Criteria (INHAND), Society of Toxicological Pathology (www.toxpath.org/inhand.asp). 
When appropriate, lesions were graded semi-quantitatively using a score from 1 to 5 
(1 = minimal, 2 = mild, 3 = moderate, 4 = marked, 5 = severe). 
For morphometric evaluation, slides with hemolymphatic tissue sections stained by 
immunohistochemistry were scanned using a digital slide scanner (NanoZoomer-XR 
C12000, Hamamatsu Photonics K.K., Iwata City, Japan), the Visiopharm Integrator 
System (Visiopharm, Hoersholm, Denmark) was used for the subsequent quantitative 
analysis. The mCD45 and hCD45 positive cell fraction areas and the number of Ku80 
(nuclear marker) positive nuclei per high power field were calculated on consecutive 
sections. The mCD45 positive cell fraction area in hemolymphatic organs 
repopulated by human cells was calculated following subtraction of the hCD45 







FACS served to identify hCD45+, CD3+, CD4+, CD8+, CD19+, NKp46+, CD4/DR+, 
CD8/DR+ populations and followed previously described protocols.2 
Peripheral blood was collected from humanized mice 3 months after human cell 
engraftment by tail vein bleeding into heparin-containing tubes (Heparin-Na, Braun). 
After two rounds of red blood cell lysis, peripheral blood mononuclear cells (PBMCs) 
were washed with PBS and stained with fluorescence coupled antibodies for 20 
minutes at 4 °C. Antibodies are listed in Table 1B. Subsequently, cells were fixed in 
4% paraformaldehyde diluted in phosphate buffered saline (PBS) for 0 to 24 hours. 
Data was acquired on the BD FACSCanto II using DIVA software and analysed using 




Statistical analysis was conducted using a Statistics Software (SPSS, 23). 
Correlation between FACS results and abundance of hCD45 positive cells in the 
lymphoid organ tissue sections was tested using Pearson test. Spearman's 
correlation analysis was used to study the relationship between GvHD and activated 
T cells. For this analysis, GvHD was divided in three categories as 0 = not present; 1 
= mild GvHD, occurring with low severity and limited distribution; and 2 = severe 
GvHD, occurring with high severity and broad distribution. Statistical significance was 





Spontaneous background lesions in NSG and hu-NSG mice, radiation-induced 
changes in hu-NSG mice  
The NSG mouse cohort (n = 48) remained healthy during the examination period and 
exhibited only a limited selection of histopathological lesions, with generally low 
severity (Table 2A). The most frequently encountered changes were minimal or mild 
multifocal alveolar macrophage accumulation with pleural thickening in the lungs; 
minimal focal tubular basophilia and tubular dilation with epithelial cell hypertrophy in 
the kidneys; minimal or mild patchy degeneration and dystrophic mineralization of 
seminiferous tubules in the testes; and minimal to moderate multifocal subcapsular 
cell hyperplasia in the adrenal glands. The latter occurred with higher frequency in 
females. Sporadically, minimal or mild focal degenerative changes in the 
intersternebral and intervertebral joints as well as cortical thickening of the femoral 
diaphysis were noted. Individual animals exhibited inflammatory processes, such as 
minimal focal neutrophilic myositis in retro-orbital and masticatory muscles, focal 
neutrophilic folliculitis in the skin of the muzzle, and a moderate diffuse chronic 
sialoadenitis. The latter appeared to be the consequence of an obstruction of the 
main excretory duct by a hair. Also, one mouse showed marked chronic pancreatitis, 
characterized by diffuse fibrosis, moderate mononuclear cell inflammation and lobular 
acinar atrophy. Apart from occasional dilation of endometrial glands, the female 
reproductive tract was free of histopathological changes. Ovaries exhibited numerous 
follicles at different stages of maturation and corpora lutea and the vagina showed 





Table 2. Spectrum of histopathological lesions in male and female NSG and hu-NSG mice 
A. NSG mice, aged 1-3 months (n=10) and 6 months (n=38) 
Organs (alphabetical order) and histological findings Males Females 
Adrenal glands   
Subcapsular cell hyperplasia 18% (5/28) 69% (11/16) 
Extramedullary hematopoiesis 7% (2/28) - 
Angiectasis (corticomedullary junction) - 13% (2/16) 
Accessory cortical tissue - 13% (2/16) 
Bones and joint   
Intersternebral joint degeneration  4% (1/28) - 
Femoral articular cartilage degeneration (clefts) 10% (3/30) - 
Intervertebral joint degeneration  3% (1/30) - 
Focal cortical thickening of femoral diaphysis 10% (3/30) 7% (1/15) 
Bone marrow (sternum and femur)   
Hemosiderosis 19% (6/31) 40% (6/15) 
Fatty infiltration (femur only) 17% (5/30) 73% (11/15) 
Myeloid hyperplasia 3% (1/31) - 
Kidneys   
Tubular dilation with epithelial cell hypertrophy 13% (4/31) 6% (1/17) 
Tubular basophilia 6% (2/31) 6% (1/17) 
Lungs   
Alveolar macrophage aggregation with pleural thickening 77% (24/31) 65% (11/17) 
Hair shaft granuloma 3% (1/31) - 
Pancreas   
Acinar atrophy with chronic inflammation 3% (1/31) - 
Salivary gland (submandibular)   
Chronic inflammation, due to foreign body (hair) - 6% (1/17) 
Skeletal muscle   
Myofibre degeneration with inflammation, retroorbital muscle - 6% (1/17) 
Myofibre degeneration with inflammation, masticatory muscle 3% (1/31) - 
Skin (muzzle)   
Neutrophilic inflammation, hair follicle - 6% (1/17) 
Spleen   
Extramedullary hematopoiesis 100% (31/31) 100% (15/15) 
Hemosiderosis 32% (10/31) 80% (12/15) 
Testes   
Seminiferous tubule degeneration with mineralization 42% (13/31)  
Thymus   
Cysts 56% (9/16) 62% (8/13) 
Thymus/mediastinal lymph node*   
Precursor T cell lymphoblastic lymphoma - 8% (1/13) 
Uterus   
Glandular dilation with luminal debris  29% (5/17) 
 






The hu-NSG mice exhibited the same type of background lesions as the NSG mice, 
and with similar frequency and severity (Table 2B). In addition, hu-NSG mice showed 
histological changes consistent with exposure to radiation in the early postnatal 
period, i.e. radiation nephropathy, cataract and impaired retinal development in the 
eye,4 and ovarian atrophy.1,6 Evidence of radiation nephropathy (deposition of 
proteinaceous material and reduced number of capillaries in glomeruli, cortical 
tubular collapse36) was observed in relatively few mice (13% of males, 17% of 
females), and with minimal severity (Figs. 1, 2). Impaired retinal development was far 
more frequent (more than 70% of animals). It ranged from a thinning of the outer 
nuclear layer and the outer segment layer, to a lack of distinction between outer and 
inner nuclear layer, leading to a very thin retina composed of a single row of nuclei 
(Figs. 3, 4). Changes were more severe in the peripheral portion of the retina. 
Cataract occurred in fewer mice (Table 2B) with low severity. Almost all female 
animals exhibited ovarian atrophy, and of varying degree. In more severe cases, the 
ovaries were reduced in size and exhibited a marked reduction to complete absence 
of oocytes, follicles and corpora lutea (Figs. 5, 6). Such animals appeared to be in 







B. Hu-NSG mice, aged 3-6 months (n=61) 
Organs (alphabetical order) and histological findings Males Females 
Adrenal glands   
Subcapsular cell hyperplasia  45% (10/22) 96% (24/25) 
Angiectasis (corticomedullary junction) - 16% (4/25) 
Accessory cortical tissue 4.5% (1/22) 8% (2/25) 
Bones and joint   
Femoral articular cartilage degeneration (clefts) - 7% (1/15) 
Bone marrow (sternum and femur)   
Fatty infiltration (femur only) 29% (4/14) 53% (8/15) 
Myeloid hyperplasia 4% (1/27) 4% (1/28) 
Granulomatous inflammation (human cells)* 30% (8/27) 14% (4/28) 
Eyes   
Impaired retinal development 73% (16/22) 75% (18/24) 
Cataract 14% (3/22) 4% (1/24) 
Kidneys   
Tubular dilation with epithelial cell hypertrophy 6% (2/31) 3% (1/30) 
Tubular basophilia - 10% (3/30) 
Radiation nephropathy 13% (4/31) 17% (5/30) 
Granulomatous inflammation (human cells)* 6% (2/31) 7% (2/30) 
Liver   
Multifocal lymphohistiocytic cell aggregates (human cells)* 26% (8/31) 17% (5/30) 
Granulomatous inflammation (human cells)* 16% (5/31) 17% (5/30) 
Extramedullary haematopoiesis 23% (7/31) 27% (8/30) 
Focal hepatocellular necrosis 3% (1/31) - 
Lungs   
Alveolar macrophage aggregation with pleural thickening 94% (29/31) 87% (26/30) 
Multifocal lymphohistiocytic cell aggregates (human cells)* 
with alveolar hemorrhage and fibrin deposition 
29% (9/31) 13% (4/30) 
Ovaries   
Atrophy - 89% (24/27) 
Pancreas   
Acinar atrophy with chronic inflammation 5% (1/22) - 
Multifocal lymphohistiocytic cell aggregates (human cells)* 5% (1/22) 8% (2/24) 
Salivary gland   
Acinar atrophy with chronic inflammation (mandibular gland) 5% (1/22) - 
Skeletal muscle   
Myofiber degeneration with inflammation, masticatory muscle 5% (1/21) - 
Skin   
Interface dermatitis with scleroderma 21% (4/19) - 
Spleen   
Extramedullary hematopoiesis 97% (28/29) 100% (29/29) 
Hemosiderosis 3% (1/29) 31% (9/29) 
Granulomatous inflammation (human cells)* 10% (3/29) 10% (3/29) 
Testes   
Seminiferous tubule degeneration with mineralization 45% (10/22)  
Thymus   
Cysts 47% (7/15) 47% (7/15) 
 
*: Ku80-positive infiltrates, considered as graft versus host disease (GvHD); see also Table 3. 







Figures 1-6. Histological changes in hu-NSG mice caused by exposure to radiations.  
Figure 1. Kidney, hu-NSG mouse. Radiation nephropathy, characterized by cortical tubular collapse (arrows). 
Figure 2. Kidney, NSG mouse, without histological changes. Figure 3. Eye, hu-NSG mouse. Impaired retinal 
development. Most normal structures of the retina cannot be identified. There appears to be an irregular ganglion 
cell layer (GCL) and a defined neuroblastic layer (NBL) of up to six cell layers. Figure 4. Eye, NSG mouse. The 
retina is unaltered. GCL - ganglion cell layer, IPL - inner plexiform layer, INL- inner nuclear layer, ONL - outer 
nuclear layer, PL - photoreceptor layer. Figure 5. Ovary, hu-NSG mouse. Ovarian atrophy. The ovary is very 
small and devoid of follicles and corpora lutea. Figure 6. Ovary, NSG mouse. Functional ovary with numerous 





Spleens, lymph node, thymus and bone marrow were compared in both groups of 
mice, in particular to comparatively assess the murine and human leukocyte 
component in hu-NSG mice. Based on previous experience of the group, hu-NSG 
mice were classified as deficiently humanized (hu-NSG(d) mice), when they exhibited 
less than 15% hCD45+ cells in the blood (determined by FACS). This applied to 
39.9% (22/61) of the animals in the present study. 
Spleen. In NSG mice, spleens were generally small, less than 12 x 2 x 1 mm in size, 
with rare, randomly distributed leukocytes (mCD45+) and no morphological evidence 
of lymphocytes populating follicles and T cell zones. Interestingly, in more than half 
(27/48) of the mice, small aggregates of mCD45+ cells were found around one or two 
arterioles, reminiscent of periarteriolar lymphoid sheaths (PALS; Fig. 7a, b). The 
aggregates were composed of round to polygonal cells of approximately 15 µm in 
diameter, with very scant cytoplasm and a large round to slightly elongated nucleus 
with finely stippled chromatin and no evident nucleolus. These cells were consistently 
negative for T cell (CD3), B cell (CD45R-B220) and macrophage (F4/80, calprotectin 
and lysozyme) markers. The red pulp was mainly populated by erythroid progenitors 
and some megakaryocytes, representing minimal to moderate extramedullary 
hematopoiesis (Fig. 7a), and scattered leukocytes; some animals also exhibited 
minimal hemosiderosis.  
Spleens were substantially larger In all hu-NSG mice, measuring approximately 15 x 
5 x 2 mm on average. Histology showed that this was due to the much higher 
cellularity of the organ secondary to human cell repopulation. While there was no 
evidence of follicular structures, human cells tended to cluster around splenic 
arterioles, forming PALS-like structures (Fig. 8) similar to but generally much larger 
than those formed occasionally by mCD45+ cells in the spleen of NSG mice. In the 
latter, due to the PAL-like aggregates, the proportion of the area in the spleen 
covered by mCD45+ cells exceeded 10% in some animals (n = 6; mean = 6.3; SD = 
±7.8) (Fig. 9), whereas murine leukocytes (mCD45+) were extremely rare in hu-NSG 
mice (Figs. 8b, 9). In contrast, they carried numerous hCD45+ cells (Fig. 8c). In 
efficiently humanized (hu-NSG(e)) mice, the hCD45 positive cell fraction area was 
21.0% on average, though the proportion varied considerably between animals 
(Table 3). In deficiently humanized mice, the hCD45 positive cell fraction area had a 
mean of 8.8% (Table 3); however, the difference between the two groups was not 
significant. The white pulp in hu-NSG mice consisted of B cells (CD20+) and T cells 
(CD3+) in equal proportions. The T cells were mostly found in the center of the 
reconstituted white pulp, in the PALS-like structures around the arteries (Fig. 10a); B 
cells tended to occupy the periphery of the white pulp but did not arrange in clear 
follicular structures (Fig. 10b). Staining for CD4 and CD8 identified mainly CD4+ T 
cells whereas only random individual cells scattered throughout the parenchyma 
were found to be CD8+. In all animals, the remaining area (red pulp) was mainly 
occupied by erythroid progenitor cells, intermingled with megakaryocytes (moderate 
extramedullary hematopoiesis) (Fig. 8a) and scattered hCD45+ leukocytes with the 
morphology of lymphocytes; these appeared to be represented by B cells and T cells 





Figures 7-10. Morphology and composition of the spleen in NSG and hu-NSG mice.  
Figure 7. NSG mouse. a. There are no distinct white pulp structures. Occasional aggregates of round cells form 
structures reminiscent of periarteriolar lymphoid sheaths (PALS) (arrows). The red pulp is cell rich, mainly due to 
extramedullary hematopoiesis (arrowheads: megakaryocytes). HE stain. b. The PALS-like structures are 
comprised of mCD45+ cells that aggregate around a splenic arteriole (arrowhead). Numerous mCD45+ cells are 
also seen randomly distributed in the red pulp. Immunohistochemistry, hemalaun counterstain. Figure 8. hu-NSG 
mouse. a. The white pulp is evident by large aggregates of lymphoid cells clustering around arterioles (large 
arrowhead), consistent with PALS. The red pulp is cell rich, with abundant extramedullary hematopoiesis (small 




Immunohistochemistry, hemalaun counterstain. c. Human leukocytes (hCD45+) form the PALS-like aggregates 
and are also distributed in moderate number throughout the red pulp (hCD45 positive cell fraction area of 13.4%). 
Immunohistochemistry, hemalaun counterstain. Figure 9. Boxplot presenting the area in the spleen of NSG and 
hu-NSG mice covered by mCD45+ cells (mCD45 positive cell fraction area in %). There is a trend towards a lower 
percentage of mCD45+ cells in hu-NSG mice, however, the difference is not statistically significant (p = 0.148). 
Figure 10. hu-NSG mouse. a. The PALS-like structures around the arteries (arrowhead) are mainly comprised of 
T cells (CD3+). b. B cells (CD20+) arrange around the PALS-like structures, without forming clear follicles. 
Immunohistochemistry, hemalaun counterstain. 
 
Lymph nodes. In NSG mice, lymph nodes were generally very small and difficult to identify 
grossly, however, in the majority of animals, the mesenteric and mandibular lymph nodes 
were successfully sampled. They were composed predominantly of connective tissue, i.e. the 
reticular stroma (Fig. 11a, b). Leukocytes (mCD45+) were present in low numbers, scattered 
throughout the fibrous scaffold (Fig. 11c, d). When sampled successfully, axillary and 
inguinal lymph nodes exhibited the same morphological features.  
Lymph nodes of hu-NSG mice were in general larger and therefore easier to identify 
grossly. Histologically, most lymph nodes were abundantly populated by lymphoid 
round cells (Fig. 12). They contained only few murine leukocytes (mCD45+; n = 33, 
mean = 0.86%, SD = ±1.8), and on average less than the lymph nodes of NSG mice 
(n = 11; mean = 2.8; SD = ±4.1) (Fig. 13). Instead, human leukocytes (hCD45+) 
repopulated the fibrous stroma (n = 33; mean = 42.1%; SD = ±22.4) (Fig. 12d). In 
efficiently humanized mice, the hCD45 positive cell fraction area had a mean of 
54.1%, whereas in deficiently humanized mice, the mean was 18.6% (Table 3). In 
some of the latter animals no human cells were identified at all; these lymph nodes 
had morphological features identical to those of the NSG mice. However, also in the 
efficiently humanized mice, repopulating hCD45+ cells appeared to distribute 
randomly across the lymph node, did not aggregate to form appreciable lymphoid 
follicles or paracortical structures, and did not allow corticomedullary distinction. 
Accordingly, CD20+ B cells which were present in moderate to high numbers, and 
CD3+ T cells which were slightly less numerous, were seen randomly distributed 
throughout the stroma. Overall, the periphery had a higher proportion of B cells (Fig. 
12b) while T cells tended to be more numerous in the center (Fig. 12c). Most T cells 





Figures 11-13. Morphology and composition of lymph nodes in NSG and hu-NSG mice.  
Figure 11. Mesenteric lymph node, NSG mouse. a. Overview of the very small lymph node. b. The higher 
magnification shows that it is mainly represented by a meshwork of fibrous tissue (reticular stroma), with low 
numbers of embedded leukocytes (arrowheads). HE stains. c. Staining for mCD45+ confirms the low number of 
leukocytes. d. Higher magnification. Immunohistochemistry, hemalaun counterstain. Figure 12. Mesenteric lymph 
node, hu-NSG mouse (well repopulated; hCD45 positive cell fraction area of 43.2%). a. The lymph node exhibits 
high cellularity, although no clear follicular and paracortical structures are identified. HE stain. b. The repopulating 
cells are B cells (CD20+) and c. T cells (CD3+) that seem to cluster to some extent but do not form follicles or T 
cell zones. d. Almost all cells are hCD45 positive. Immunohistochemistry, hemalaun counterstain. Figure 13. 
Boxplot presenting the area in the lymph nodes of NSG and hu-NSG mice covered by mCD45+ cells (mCD45 
positive cell fraction area in %). There is a trend towards a lower percentage of mCD45+ cells in hu-NSG mice, 
however, this is not statistically significant (p = 0.059). 
 
Thymus. In NSG mice, the thymus was generally barely visible and composed of hypoplastic 
lobules that lacked a defined cortex and medulla and often contained cysts, as previously 
reported (Fig. 14).7 Again, leukocytes (mCD45+) were rare (Fig. 15). 
The thymus generally appeared slightly larger in hu-NSG mice, with an approximate 
size of 2 x 1 x 1 mm. Lobules were more cellular and exhibited moderate numbers of 
lymphoid cells (Fig. 16), but still lacked the typical corticomedullary distinction. Murine 




(Fig. 17). Still, mCD45+ cells were sometimes more numerous than in NSG mice, 
where the area covered by mCD45+ cells did not exceed 0.3% (n = 9; mean = 0.09; 
SD = ±0.1) (Fig. 17). Repopulation with hCD45+ leukocytes was variable in hu-NSG 
mice. In efficiently humanized mice, the mean of the hCD45 positive cell fraction area 
reached 46.1%, whereas it was 16.5% in deficiently humanized mice (Table 3). The 
majority of these cells were CD3+. Of this subpopulation most cells were CD4+ 
whereas CD8+ cells were only visible in very small numbers. CD20+ cells were barely 
present. 
 
Figures 14-17. Morphology and composition of the thymus in NSG and hu-NSG mice. 
Figures 14, 15. NSG mouse. Figure 14. Hypoplastic thymus without defined cortex and medulla, devoid of 
lymphocytes and with a large cyst (*). HE stain. Figure 15. Leukocytes (mCD45+) are found in low numbers and 
randomly distributed (arrowheads). Immunohistochemistry, hemalaun counterstain. Figure 16. hu-NSG mouse. a. 
Cortex and medulla cannot be identified, but there is a moderate cellularity with numerous disseminated lymphoid 
round cells. HE stain. b. Murine leukocytes (mCD45+) are found disseminated and in low numbers. c. The vast 
majority of the round cells are hCD45+ human leukocytes, confirming repopulation (hCD45 positive cell fraction 
area of 42.6%). Immunohistochemistry, hemalaun counterstain. Figure 17. Boxplot presenting the area in the 
thymus of NSG and hu-NSG mice covered by mCD45+ cells (mCD45 positive cell fraction area in %). There is no 





One 6-month-old female breeding NSG mouse exhibited a white-tan, firm mass of 
approximately 0.4 cm in diameter in the thoracic cavity. Histologically, it was 
composed of dense sheets of large round neoplastic cells which also infiltrated the 
adjacent adipose tissue (Fig. 18). The cells exhibited scant amphophilic cytoplasm 
and round nuclei with coarsely arranged chromatin. There was moderate 
anisocytosis and a mitotic rate of 2-4/HPF; a moderate number of apoptotic cells was 
observed (Fig. 19a). The vast majority of cells were found to express CD3 and CD4 
(Fig. 19 b, c), whereas B cells (CD45R+) were seen in low numbers and randomly 
distributed. This led to the diagnosis of a precursor T cell lymphoblastic lymphoma.34 
It was not possible to determine whether the neoplasia originated from the thymus or 
the mediastinal lymph nodes. The mouse did not exhibit further neoplastic masses or 
any other histopathological changes.  
 
Figures 18, 19. T cell lymphoblastic lymphoma, thoracic cavity, NSG mouse, 6 months, female. 
 
Figure 18. Thoracic mass composed of a monomorphic neoplastic cell population that also infiltrates the adjacent 
mediastinal adipose tissue. HE stain. Figure 19. a. Neoplastic cells are arranged in tightly packed sheets and 
display scant amphophilic cytoplasm, round nuclei with coarsely arranged chromatin, and moderate anisocytosis. 
There are several mitotic (arrows) and apoptotic (arrowheads) cells. HE stain. b. The vast majority of neoplastic 
cells express the pan T cell marker CD3. c. Neoplastic cells are also CD4 positive (pink reaction along the cell 
border), but CD8 negative (blue reaction along the cell border). Immunohistochemistry, hemalaun counterstain. 
 
Bone marrow. In NSG mice, the bone marrow (sternal and femoral) generally exhibited a 
high cellularity, represented by erythroid, mCD45+ myeloid and megakaryocytic 
hematopoietic precursors (Fig. 20).  Mild to moderate hemosiderosis as well as fatty 
infiltration (femur only) was occasionally seen (Table 2A). 
In hu-NSG mice, the morphology of the bone marrow was similar, with high cellularity 
(Fig. 21). While mCD45+ cells were very rare, making up a significantly lower 




cell population (Fig. 21c). A comparison of the number of human cells (Ku80+) in 
efficiently and deficiently humanized mice revealed a significantly higher proportion of 
human cells in efficiently humanized mice (Table 3). 
 
Figures 20-22. Morphology and composition of the femoral bone marrow in NSG and hu-NSG mice.  
Figure 20. NSG mouse. a. The bone marrow is cell rich; all hematopoietic cells are represented. HE stain. b. 
There are abundant mCD45+ leukocytes. Immunohistochemistry, hemalaun counterstain. Figure 21. hu-NSG 
mouse. a. The bone marrow is highly cellular; all hematopoietic cell lineages are represented. HE stain. b. The 
number of mCD45+ cells is extremely low, positive cells are often apoptotic (arrowheads). c. The vast majority of 
cells are hCD45+ leukocytes. Immunohistochemistry, hemalaun counterstain. Figure 22. Boxplot presenting the 
area in the bone marrow of NSG and hu-NSG mice covered by mCD45+ cells (mCD45 cell fraction area in %). A 









Table 3. Human cells in the lymphoid organs of efficiently humanized NSG mice (hu-NSG mice; animals with 
more than 15% hCD45 cells in the blood at the age of three months) and deficiently humanized NSG mice (hu-
NSG(d) mice; animals with less than 15% hCD45 cells in the blood at the age of three months). The area covered 
by human cells (hCD45+) in spleen, lymph nodes, thymus, and the number of Ku80-positive human cells in the 
bone marrow was measured. Significant differences were tested between hu-NSG and hu-NSG(d) using t test. 
 












Spleen 8.4 - 46.8 21.0 13.9 0.1 - 35.5 8.8 12.8 p = 0.87 
Lnna 41.8 - 59.5 54.1 6.5 0.0 - 51.2 18.6 24.3 p = 0.008 
Thymus 27.9 - 65.2 46.1 11.8 0.0 - 65.2 16.5 27.5 p = 0.030 
BMb 42.3 - 88.4 69.6 15.0 0.5 - 56.3 28.2 23.3 p = 0.001 
 
Lnn - lymph nodes; BM - bone marrow 
aThe mean of hCD45+ area of the detected, i.e. histologically examined lymph nodes in each animal was taken 
for the calculation. 
bhu-NSG mice: n = 12; hu-NSG(d) mice: n = 4 






Graft versus host disease (GvHD) in CD34+ hu-NSG mice 
Two male and two female hu-NSG mice developed poor health before study 
completion and were electively euthanized, the females at 28 weeks after HSC 
transplantation due to severe progressive weight loss, and the males at 30 weeks. 
Both were thin and had exhibited signs of unease such as hunched posture, rough 
coat and reddened skin. All four mice exhibited grossly enlarged lymph nodes and 
spleen, a diffusely pale bone marrow, and a red and white mottled liver. The 
histological examination revealed extensive granulomatous inflammatory infiltrates in 
these tissues as well as in the kidneys (Figs. 23-29). There was no evidence of 
bacterial or fungal organisms within the inflammatory infiltrates, as confirmed by 
various special stains (Gram, Giemsa, Periodic acid Schiff, Grocott, and Ziehl-
Neelsen). Therefore, the inflammatory processes were considered a manifestation of 
GvHD.11,45 They were represented by multifocal to coalescing, partly nodular 
aggregates of macrophages and epithelioid cells, admixed with numerous lymphoid 
and multinucleated giant cells (Figs. 23-29). In the infiltrates, cells were often found to 
proliferate, which was reflected by the presence of mitotic cells (1-3 mitotic figures 
per high power field). The vast majority of cells were human leukocytes (Ku80+ (Fig. 
24b), hCD45+), with only very few intermingled murine (mCD45+) leukocytes. 
Macrophages and T cells (CD3+) dominated in the infiltrates which also contained a 
variable portion of B cells and a few viable neutrophils (Fig. 24c, d).  A combined 
immunohistochemical stain for CD4 and CD8 antigens revealed a striking 
predominance of CD4+ T cells, with only rare CD8 or double positive cells. In the 
liver, GvHD consisted of lymphohistiocytic or granulomatous infiltrates that were 
mainly located in periportal areas (Figs. 23, 24a) and were associated with minimal to 
moderate deposition of fibrous connective tissue as well as scattered hemosiderin-
laden macrophages. Bile ducts were often embedded within the inflammatory 
reaction, but were neither altered nor infiltrated, suggesting that they were not 
targeted by the inflammatory cells at this stage. Bone marrow affection was 
represented by scattered nodules randomly distributed in the hematopoietic tissue 
(Fig. 25a) to subtotal replacement of the hematopoietic cell component by, in the 
majority, MHC II positive cells (Fig. 25b), with concurrent bone marrow necrosis and 
hemorrhage as well as bone resorption. Affected spleens and lymph nodes (Figs. 26-
29) showed scattered focal infiltrates or severe disruption of the architecture by the 
inflammatory infiltrates. When affected, kidneys exhibited only mild changes, 
represented by scattered granulomatous foci randomly distributed throughout the 
cortical interstitium. In individual cases, pancreas, ovaries, serosae, Harderian 
glands, nose and/or oral cavity also showed granulomatous infiltrates. 
Some animals with the above-described GvHD lesions also exhibited inflammatory 
infiltrates in lungs and skin. In the lungs, these represented peribronchiolar and 
perivascular aggregates of Ku80-positive cells, which were predominantly T cells and 
B cells, with fewer macrophages. Infiltrates occasionally extended into the 
bronchiolar and alveolar lumina. In the skin, minimal or mild infiltration of Ku80-
positive, predominantly CD4+ and fewer CD8+ T cells and rare B cells was seen 
along the dermo-epidermal junction, associated with vacuolar change and occasional 
apoptosis in the basal follicular keratinocytes and, to a lesser extent, the basal 
epidermal keratinocytes.  
Granulomatous inflammatory infiltrates were also observed in other mice, with lower 
severity and higher incidence in males (21%; 6/29) than in females (11%; 3/28). 
Liver, spleen, lymph nodes, bone marrow at different locations (sternum, femur and 
tibia, vertebrae and frontal bones in the skull) and kidneys were most consistently 





Table 4. Incidence and severity of granulomatous and/or mononuclear inflammatory infiltration (mediated by 
human cells) in the organs of hu-NSG mice.  
 
Organ Sex 
Granulomatous inflammatory infiltration 
Minimal Mild Moderate Marked Severe 
Bone marrow Male 2 1 3 (1) - 1 (1) 
 Female 2 - - 1 (1) 1 (1) 
Kidneys Male 3 2 (2) - - - 
 Female 1 1 (1) - - - 
Liver Male 1 - 3 (1) 1 (1)  
 Female - 2 2 (1) 1 (1) - 
Lungs* Male - 3 (1) 1 (1) - - 
 Female 1 1 (1) - - - 
Lymph nodes Male - 3 (2) 2 - - 
 Female 1 1 (1) - - - 
Skin* Male 2 (1) 2 - - - 
 Female - - - - - 
Spleen Male - 1 1 (1) - 1 (1) 
 Female 1 (1) - - - - 
 
*Lesions were dominated by mononuclear cell infiltrates without typical granulomatous character. 
Numbers give the total numbers of affected animals; numbers in brackets indicate how many of the affected 






Figures 23-29. Graft versus host disease (GvHD), hu-NSG mouse.  
Figures 23, 24. Liver. Figure 23. There are multifocal inflammatory infiltrates, mainly arranged around portal 
areas. Portal vein (*). HE stain. Figure 24. a. Cells in the focal infiltrates predominantly have the morphology of 
macrophages and lymphocytes. HE stain. b. Almost all cells in the infiltrates are Ku80-positive, confirming their 
human origin. c. A large proportion of cells in the infiltrate are T cells (CD3+). Portal vein (*). d. A moderate 
proportion of cells in the infiltrate are B cells (CD20+). Immunohistochemistry, hemalaun counterstain. Figure 25. 
Bone marrow. a. Within the hematopoietic tissue are variably sized aggregates of larger mononuclear cells 
(arrows). HE stain. b. The majority of cells in such focal aggregates are MHC II, suggesting that there are 
abundant macrophages and activated lymphocytes. Immunohistochemistry, hemalaun counterstain. Figures 26, 
27. Spleen. Figure 26. The red pulp is widely replaced by large granulomatous infiltrates (arrows). Figure 27. 
Closer view of granulomatous infiltrate with epithelioid cells (arrowhead) and multinucleated cells (arrow). HE 
stains. Figures 28, 29. Cervical lymph node. Figure 28. The normal architecture is widely replaced by 




Correlation between engraftment levels in blood and lymphoid tissues of hu-NSG 
mice 
The FACS analysis performed on the peripheral blood of the hu-NSG mice revealed a large 
variability in the proportion of human leukocytes (hCD45+), ranging from 0.14% to 66.5% 
(Fig. 30). As mentioned above, mice with more than 15% hCD45+ cells in the blood were 
considered as efficiently humanized (Figs. 30a, 31a), and below this threshold as deficiently 
humanized (Figs. 30b, 31b). 
Figures 30, 31. Comparison of efficiently humanized (hu-NSG(e)) and deficiently humanized (hu-NSG(d)) NSG 
mice.  
 
Figure 30. Proportion of human cells in the blood (hCD45+, FACS) and lymphoid organs (hCD45+, 
immunohistochemistry). a. hu-NSG(e) mice. b. hu-NSG(d) mice. Each colour represents one individual. Note the 
large variability among the different individuals but also in the organs of the single individuals. Grouping of the 
mice followed FACS analysis (cut off 15% hCD45). Lymph node values include the average of all detected lymph 
nodes in each animal (axillary, cervical and mesenteric). Animals with histological lesions interpreted as GvHD 
are marked with an asterisk. Only organs without lesions were evaluated. Figure 31. Proportion of human cells in 
the blood (hCD45+, FACS) and bone marrow (Ku80+, immunohistochemistry). a. hu-NSG(e) mice. b. hu-NSG(d) 
mice. Each dot represents one individual. Note the large variability among the different individuals but also in the 
organs of the single individuals, especially in the group of hu-NSG(d) mice. Animals with histological lesions 
interpreted as GvHD are marked with an asterisk. 
 
Immunohistochemistry against hCD45+ was performed on the lymphoid organs of a 
proportion of efficiently and deficiently humanized mice (each n = 8) to explore correlation 
with the FACS data. As expected, this grouping of mice matched to some extent with the 
degree of repopulation of the hemolymphatic organs, as overall the percentage of human 
cells was significantly higher in lymph nodes, thymus and bone marrow of the efficiently 
humanized mice (Table 3). Interestingly, there was no substantial difference in the spleen. 
This may be due to the overall low relative extent of repopulation of this organ, which still 
contains a significant proportion of murine hematopoietic cells; even in efficiently humanized 
mice, the mean percentage area covered by human leukocytes (hCD45+) was 21.0%, 
whereas it was 46.1% and 54.1% in thymus and lymph nodes respectively (Table 3). 
However, looking at repopulation levels in the different organs of individual animals it 
became obvious that there is substantial variation. Also, a mouse classified as 
deficiently humanized can have a proportion of human cells in the bone marrow (i.e. 




later appear in the blood stream) that is as high as that seen in efficiently humanized 
mice (Fig. 8b, d). 
The FACS results of animals with histological changes consistent with GvHD (n = 13) 
were compared with those of mice without such lesions (n = 48). Interestingly, GvHD 
animals were found to have significantly lower proportions of human leukocytes 
(Table 5). The human leukocyte population contained significantly lower proportions 
of lymphocytes and B cells, but significantly higher proportions of T cells and 
monocytes. There were also significantly more activated T cells, activated T helper 
cells and activated cytotoxic T cells (Table 5), as confirmed using Spearman's 
correlation analysis (correlation coefficient of 0.630 for CD4DR+ and of 0.661 for 
CD4DR+ cells). 
 
Table 5. Cellular composition (proportions) of the peripheral blood in animals with histological evidence of graft 
versus host disease (GVHD) compared to animals without.  
 
 
Human leukocytes (a) were identified based on the expression of hCD45. The hCD45+ cells were subsequently 
separated further into lymphocytes (b) based on their size in the forward and sideward scatter, as well as T and B 
cells based on the expression of CD3 and CD19, respectively. HLA-DR co-expression identified activated T cells, 
activated T helper and activated T killer cells (c), whereas monocytes (d) were cells negative for all other markers, 
but HLA-DR positive. 
Statistical analysis was done using t test. 
  
Cell type 





Mean ± SD Mean ± SD 
Leukocytesa 63.1% 13.0 39.0% 21.3 0.002 ↓ 
Lymphocytesb 74.9% 12.5 53.0% 21.0 0.003 ↓ 
T cells (CD3+) 26.2% 10.6 35.9% 20.1 0.040 ↑ 
B cells (CD19+) 66.5% 11.5 26.1% 9.8 0.020 ↓ 
Activated T cells 
(CD3+/HLA-DR+)c 
5.7% 5.0 20.5% 12.3 0.001 ↑ 
Activated T helper cells 
(CD4+/HLA-DR+) c 
3.4% 2.7 14.4% 13.3 0.010 ↑ 
Activated cytotoxic T 
cells  (CD8+/HLA-DR+) c 
9.6% 9.3 29.6% 19.5 0.003 ↑ 





Data illustrating the spectrum of spontaneous and experimentally induced diseases in 
humanized mice are very limited, and the situation is similar for the recipient NSG 
immunodeficient mice. Besides, detailed characterization of the morphological 
aspects of repopulation at tissue level is highly desirable to allow accurate correlation 
with the engraftment features obtained via FACS analysis. This study aimed to 
characterise the morphological phenotype of NSG mice and their humanized 
counterpart, the CD34+ hu-NSG murine model, and to gather data on the most 
common background lesions in both types of mice. In addition, a comparative 
quantitative assessment was undertaken in the attempt to relate levels of human 
repopulation in the hemolymphatic organs of hu-NSG mice to FACS results obtained 
from the peripheral blood, as the latter is commonly used as a tool to determine the 
extent of humanization. 
Full histological examination of a cohort of 48 NSG mice aged 3 to 6 months revealed 
a limited spectrum of background lesions, occurring with low severity. Salient 
changes were observed in lungs, kidneys, testes and adrenal glands and were all 
among those commonly encountered also in other strains13,17,39. In addition, there 
was a very low prevalence of incidental inflammatory changes, without evidence of 
infectious conditions. This can likely be ascribed to housing of the mice under specific 
pathogen free conditions as in general NSG mice are prone to infections because 
their immune system is compromised.16 Since the present study focused on young 
animals, it cannot provide data on potential spontaneous neoplastic processes that 
might develop with age.41 Interestingly though, a lymphoma was found in the thoracic 
cavity of a 6-month-old non-irradiated female NSG mouse, which could have 
originated from the thymus or the mediastinal lymph nodes. The tumor was 
predominantly composed of CD3+, CD4+ T cells and further characterized as a T cell 
lymphoblastic lymphoma. Hematopoietic neoplasms are reported to occur with low 
prevalence in NSG mice, in subjects older than 1 year,16,41 due to the inactivation of 
IL-2Rγ, which plays an important role in the signalling pathways for B and T cell 
growth.25 In the present case, it could be a spontaneous event that might have 
compensated for IL-2Rγ deficiency, and led to full manifestation of the NOD-scid 
background phenotype, which has been reported to frequently develop lymphomas.37 
Lymphomas, especially thymic lymphomas might also occur secondarily to 
irradiation, which is used to deplete mouse hematopoietic cells prior to human cell 
engraftment, or insertional mutagenesis resulting from gene editing therapeutic 
products. Hence, it is crucial to report on the occurrence of such tumors in untreated 
NSG mice at an age when they are used in transplantation experiments, to build up 
an accurate historical database. 
All NSG mice in the present study showed poorly developed lymphoid organs, 
lacking the typical lymphoid tissue architecture. This has previously been reported as 
a feature in the lymphoid organs of several immunodeficient murine lines, including 
NSG mice, whose genetic manipulation leads to severe impairment of immune 
functions.7,41,42,44 However, we observed small or moderately sized periarteriolar 
clusters of mCD45+ cells in the spleen of numerous NSG mice, a feature that has so 
far not been reported. Cells in these clusters did not express more specific 
lymphocyte or macrophage markers, so further work is needed to assess their exact 
nature and whether they represent early lymphoid precursors, dendritic or myeloid 
subsets. According to the experience of the authors, these aggregates can be a 
confounding factor in studies employing NSG mice engrafted with human 
hematopoietic cells or administered cell-based therapy products, which might have 




interesting observation was that, like the bone marrow in scid and other 
immunodeficient mouse lines, the bone marrow of NSG mice did not show major 
histological abnormalities in the hematopoietic cell component.14  
The comprehensive histological screening of hu-NSG mice, i.e. NSG mice engrafted 
with human CD34+ HSC, revealed a spectrum of spontaneous lesions similar to that 
observed in naïve NSG mice. However, the mice additionally exhibited changes that 
can be ascribed to either the preconditioning irradiation or the engraftment of human 
hematopoietic cells.  
Among the lesions potentially related to perinatal total body irradiation, to which the 
scid mutation of NSG mice renders them particularly sensitive,5 were nephropathy, 
ovarian atrophy and ocular changes, all three well-known complications of radiation 
exposure in humans.3,12 Radiation nephropathy has also been described in different 
preclinical species including mice.12 In both humans and laboratory animals it 
represents a late onset, adverse event following external beam irradiation or 
radionuclide therapy, characterized by concurrent injury to glomerular and tubular 
compartments.12,36 In the present study it was observed with low frequency and 
severity, which suggests an early stage of the disease in the still young hu-NSG 
mice. So far, both ovarian atrophy and retinal changes have only been sporadically 
reported as radiation-induced alterations in animal models, and the present report is 
the first of such lesions in hu-NSG mice undergoing perinatal preconditioning. 
Interestingly, both types of changes occurred with high prevalence and severity, 
indicating a high sensitivity of ovaries and retina of these mice to irradiation. It is 
known that the germline cells in the ovary are highly susceptible to radiation damage 
and that accelerated reproductive aging can occur when the follicle pool, which is 
finite and non-renewable, is damaged due to irradiation.1 From the present findings it 
could be speculated that radiation-induced damage of the female germ cells at an 
early prepubertal stage might cause loss of ovarian reserve, which then manifests as 
atrophy of the gonads and lack of cyclical changes in uterus and vagina. 
Interestingly, there were no substantial microscopic changes in the testes of hu-NSG 
mice, suggesting that the irradiation procedure did not affect the male germline. This 
difference might be due to different radiation exposure or reduced sensitivity of the 
male gonadal tissues in the postnatal period, as previously reported.15 Radiation 
retinopathy in humans encompasses a number of retinal changes following exposure 
to radiations from any source, typically external beam radiation exposure in patients 
affected by nasopharyngeal, sinusal or orbital tumors.3 In animal models, the 
occurrence of ocular radiation complications has recently been reported as rare, most 
frequently affecting the lens as cataracts, which also occurred in this study with low 
prevalence and low severity.38 The retinal lesions observed in our mouse cohort 
suggest a perinatal stop of the retinal development, allowing only the neuroblastic 
layer and the ganglion cell layer to be identified51, and, to our knowledge, they have 
not been previously reported in mice that have undergone total body irradiation. 
Extensive photoreceptor loss and impaired retinal development in the hu-NSG mice 
might therefore be linked to radiation exposure in the perinatal period, when cell 
proliferation is still ongoing in the retina as part of the postnatal development process. 
Nonetheless, a more thorough investigation of the retinal changes was beyond the 
scope of the present study, as it would require dedicated long-term studies with 
multiple endpoints and multiple radiation quantities. Notably though, researchers 
should be aware of potential impaired vision resulting from the retinal lesions. 
The changes that can be ascribed to the engraftment of human hematopoietic cells 
are represented by granulomatous inflammatory infiltrates of almost exclusively 




absence of microorganisms and foreign material and the dominance of macrophages 
and CD4+ T cells suggest an underlying human-anti-mouse immunopathological 
process. Accordingly, these granulomatous processes were interpreted as a 
manifestation of GvHD, a condition that has been reported in several humanized 
mouse models;11,20 some of which are employed to study the pathogenesis of 
GvHD43. Typical GvHD lesions described in both mice and humans include T cell-
mediated, lymphocyte-rich portal hepatitis, enteritis and dermatitis, and the latter was 
also observed in some animals in the present study. However, the predominance of 
granulomatous lesions in 20% of hu-NSG mice points to a loss of human CD4+ T cell 
tolerance against the mouse host.11,45 These CD4+ T cell responses might be favored 
by the NOD mouse strain background of hu-NSG mice. NOD mice spontaneously 
develop CD4+ T cell mediated autoimmunity in various organs, starting with β-cell 
destruction in pancreatic islets, leading to diabetes.50 GvHD has been reported as a 
major cause of morbidity also in other studies employing humanized mice, however 
the prevalence of GvHD appears much lower  (7% of the reconstituted hu-NSG 
animals) in the present cohort than in other models.20,26. Since the affected mice do 
not reach the experimental end-point they are often excluded from the analysis and 
the frequency of the respective pathological changes, whose underlying cause is 
ascribed to GvHD, is rarely reported.3 In the present study, GvHD was only observed 
in one out of thirteen mice that did not show weight reduction or clinical signs, but still 
exhibited granulomatous lesions, with more males found to be affected (21%) than 
females (11%). These data indicate that monitoring of weight loss and clinical signs 
can identify the majority of mice with GvHD. Still, some mice with only few and mild 
lesions that can only be detected by a histological examination may not be identified 
and show an aberrant immunological response of the engrafted human cells in 
different types of experiments. It is important to highlight though that the prevalence 
and features of GvHD reported here might solely apply to the model employed in our 
study, as there is growing evidence that the incidence and severity of GvHD varies 
extensively across experiments depending on the source, number and manipulation 
of human donor cells employed and the features of the recipient host system (e.g. 
strain susceptibility, environmental features and preconditioning protocols involving 
irradiation or chemotherapy).19,32 
In the present study, the in situ detection of human and murine cells in the 
hemolymphatic tissues provided information on the extent and distribution of homing 
of graft and host leukocytes after humanization with CD34+ HSC. We observed that 
the mouse component (mCD45+ cells) generally decreased with humanization of the 
animal, even though the difference was not statistically significant. This phenomenon 
cannot be explained without further studies employing larger numbers of animals. It 
could simply be a consequence of irradiation; alternatively, it is possible that the 
introduction of human cells leads to a reduced proliferation of the murine leukocytes. 
Both FACS data and the image analysis of tissue sections of hemolymphatic organs 
suggested that the extent of hCD45+ repopulation was highly variable among the 
engrafted animals. The reason for this is not clear, but pre-treatment, injection route 
and source of HSCs will inevitably have an impact on the inter- and intra-
experimental variability of engraftment. This make comparisons across different 
models difficult, even when experimental conditions vary only slightly. Human cells 
showed a variable distribution in the different organs. In the spleen, hCD45+ cells 
formed aggregates reminiscent of the white pulp of immunocompetent mice, despite 
the absence of discernible PALS and lymphoid follicle organisation. The thymus of 
hu-NSG mice was variably repopulated by human T cells, providing further evidence 




not observed. In the lymph nodes, however, there was no evidence of a cell type 
specific arrangement. It has previously been suggested that the genetic background 
of the mice is responsible for the lack of the typical architecture in the lymphoid 
organs,  as cytokines like lymphotoxin (LT) are essential for their appropriate 
development.29 The architecture is crucial for the proper functionality of the immune 
system,35 and it has been suggested that the poorly organized lymphoid organs are a 
limiting factor in the humoral immune response of humanized mice.53 Repopulation of 
the bone marrow seems to be less complicated; in GvHD lesion-free bone marrows 
all cell types appeared to home effectively. 
The present study also investigated whether there is any correlation between the 
pattern and extent of reconstitution in the lymphoid organs by human leukocytes and 
the results of the FACS analysis on the peripheral blood. The FACS analysis 
revealed a high variability in reconstitution between the different animals, at the same 
time the actual distribution of hCD45+ in the lymphoid organs of an individual can be 
quite variable. Upon pairing the obtained FACS data of the reconstitution 3 to 6 
months after human HSC injection with the morphological analysis of the lymphoid 
organs it becomes evident that a high reconstitution does not necessarily go in hand 
with a high repopulation at the tissue level. In the efficiently humanized mice there 
was no significant correlation between the level of circulating hCD45+ cells and 
hCD45+ cells in the organs, whereas a significant correlation was seen in the 
deficiently humanized animals. This significance may be due to the low hCD45+ cell 
levels in all the compartments and thus a lower variability. 
In the animals affected by GvHD the proportion of human leukocytes and 
lymphocytes in the blood were significantly reduced compared to mice that did not 
exhibit evidence of GvHD. This might result from migration of human leukocytes from 
the blood stream to the sites of injury, similarly to what occurs in infections and 
sepsis,47 and by compromised hematopoietic function due to GvHD lesions in the 
bone marrow, as it was visible in the histological evaluation of some of the animals. 
However, compared to the cohort not affected by GvHD, the proportion of T cells in 
the blood was significantly increased, as well as the numbers of activated T cells, 
activated T helper cells and activated cytotoxic T cells. The increased numbers of T 
cells fit with the central role of effector graft donor T cells in driving GvHD 
development.10,32 Moreover, the granulomatous lesions in the bone marrow of 
affected animals were dominated by MHC II-positive cells, and also activated T cells 
are known to express this surface antigen.28 This hypothesis is supported by a study 
that shows an increase in the proportion and extent of fluctuation of CD3+CD4+CD8β+ 
T cells.10  
Identification of an increase in T cells, primarily activated helper T cells in the FACS 
data might help to spot individual mice affected by subclinical GVHD, which could 
then be confirmed via the histological examination of typically affected organs such 
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